Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...

Cancer prevention focuses on the body's internal environment. Dr Berg highlights supporting cellular energy, metabolism, and ...

Jefferies London Healthcare Conference 2025 November 17, 2025 10:00 AM ESTCompany ParticipantsLawrence Blatt - ...

Scientists have identified a typical household and dry cleaning ingredient as a new risk factor for severe, potentially fatal liver damage. The compound tetrachloroethylene (PCE), commonly used in dry ...

Explore the critical link between obesity and cancer, highlighting risks, prevention, and innovative treatments for better ...

A physician-scientist who last year joined the University of Colorado Cancer Center team will soon steer the first human ...

A health insurance dispute is preventing a North Carolina man from getting a cancer drug his doctors say is necessary. The prognosis for John Middleton isn’t good. The 43-year-old engineer from ...

The University of Oxford is part of a £15.9 million UK-wide programme to develop human tumour tissue models, improving cancer ...

Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced the presentation of new preclinical data from its lead clinical pipeline, ...